Zi Li

Title: The Innovative Contributions of Inventor Zi Li

Introduction

Zi Li is a prominent inventor based in Yunnan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit thrombotic diseases. With a total of 4 patents to his name, his work has garnered attention for its potential impact on medical treatments.

Latest Patents

Zi Li's latest patents include an innovative oligosaccharide compound designed to inhibit the intrinsic coagulation factor X-enzyme complex. This compound has demonstrated antithrombotic activity and is accompanied by a preparation method and various uses in pharmaceutical compositions. Another notable patent involves a Fuc3S4S substituted oligoglycosaminoglycan, which has a weight-average molecular weight of approximately 4.5-9 kD. This compound is also aimed at preventing and treating thrombotic diseases, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Zi Li has worked with reputable companies such as Jiuzhitang Co., Ltd. and Mudanjiang Youbo Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in pharmaceutical research.

Collaborations

Zi Li has collaborated with notable colleagues, including Jinhua Zhao and Mingyi Wu. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Zi Li's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in the treatment of thrombotic diseases.